Family-based association between alzheimer's disease and variants in UBQLN1

New England Journal of Medicine

Volumn 352, Issue 9, 2005, Pages 884-894

  Bertram, Lars ^a   Hiltunen, Mikko ^a   Parkinson, Michele ^a   Ingelsson, Martin ^a   Lange, Christoph ^c   Ramasamy, Karunya ^a   Mullin, Kristina ^a   Menon, Rashmi ^a   Sampson, Andrew J ^a   Hsiao, Monica Y ^a   Elliott, Kathryn J ^d   Velicelebi, Gonül ^d   Moscarillo, Thomas ^b   Hyman, Bradley T ^a   Wagner, Steven L ^d   Becker, K David ^d   Blacker, Deborah ^b,c   Tanzi, Rudolph E ^a,b  

^a MassGeneral Inst for Neurodeg Dis   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d Neurogenetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA; PROTEIN UBIQUILIN 1; UBIQUITIN; UNCLASSIFIED DRUG; ABC TRANSPORTER; ABC TRANSPORTER A1; APBA1 PROTEIN, HUMAN; CARRIER PROTEIN; CELL CYCLE PROTEIN; NERVE PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; UBQLN1 PROTEIN, HUMAN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN TISSUE; CHROMOSOME 9Q; CONTROLLED STUDY; FEMALE; GENE MAPPING; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM; BRAIN; CASE CONTROL STUDY; CHROMOSOME 9; COHORT ANALYSIS; DNA SEQUENCE; GENETIC TRANSCRIPTION; GENETICS; GENOTYPE; HAPLOTYPE; MIDDLE AGED; PATHOLOGY; RISK FACTOR; STATISTICAL MODEL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATP-BINDING CASSETTE TRANSPORTERS; BRAIN; CARRIER PROTEINS; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN, PAIR 9; COHORT STUDIES; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE (GENETICS); LOGISTIC MODELS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC;

EID: 20044362721     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa042765     Document Type: Article

References (31)

1. Tanzi RE. A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders. J Clin Invest 1999;104:1175-9.
2. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 1993;90:1977-81.
3. Saunders AM, Strittmater WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-72.
4. Daw EW, Payami H, Nemens EJ, et al. The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet 2000;66:196-204.
5. Blacker D, Bertram L, Saunders AJ, et al. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 2003;12:23-32.
6. Bertram L, Tanzi RE. Alzheimer's disease: one disorder, too many genes? Hum Mol Genet 2004;Special No. 1:R135-R141.
7. Wollmer MA, Streffer JR, Lutjohann D, et al. ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Neurobiol Aging 2003;24:421-6.
8. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of NINCDS-ADRDA WorkGroup under the auspices of Department of Health and Human Services Task Forces on Alzheimer's Disease. Neurology 1984;34:939-44.
9. Blacker D, Albert MS, Bassett SS, Go RC, Harrell LE, Folstein MF. Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. Arch Neurol 1994;51:1198-204.
10. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86.
11. Hyman BT, Trojanowski JQ. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 1997;56:1095-7.
12. Ingelsson M, Fukumoto H, Newell KL, et al. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in Alzheimer's disease brain. Neurology 2004;62:925-31.
13. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996;58:1347-63.
14. Kong A, Cox NJ. Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet 1997;61:1179-88.
15. Rabinowitz D, Laird N. A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. Hum Hered 2000;50:211-23.
16. Horvath S, Xu X, Lake SL, Silverman EK, Weiss ST, Laird NM. Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics. Genet Epidemiol 2004;26:61-9.
17. Lake SL, Blacker D, Laird NM. Family-based tests of association in the presence of linkage. Am J Hum Genet 2000;67:1515-25.
18. Martin ER, Monks SA, Warren LL, Kaplan NL. Atest for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet 2000;67:146-54.
19. Martin ER, Bass MP, Kaplan NL. Correcting for a potential bias in the pedigree disequilibrium test. Am J Hum Genet 2001;68:1065-7.
20. Eskin E, Halperin E, Karp RM. Efficient reconstruction of haplotype structure via perfect phylogeny. J Bioinform Comput Biol 2003;1:1-20.
21. Li C, Scott LJ, Boehnke M. Assessing whether an allele can account in part for a linkage signal: the Genotype-IBD Sharing Test (GIST). Am J Hum Genet 2004;74:418-31.
22. Witte JS, Gauderman WJ, Thomas DC. Asymptotic bias and efficiency in case-control studies of candidate genes and gene-environment interactions: basic family designs. Am J Epidemiol 1999;149:693-705.
23. Wu AL, Wang J, Zheleznyak A, Brown EJ. Ubiquitin-related proteins regulate interaction of vimentin intermediate filaments with the plasma membrane. Mol Cell 1999;4:619-25.
24. Mah AL, Perry G, Smith MA, Monteiro MJ. Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation. J Cell Biol 2000;151:847-62.
25. Kleijnen MF, Shih AH, Zhou P, et al. The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome. Mol Cell 2000;6:409-19.
26. Bedford FK, Kittler JT, Muller E, et al. GABA(A) receptor cell surface number and subunit stability are regulated by the ubiquitin-like protein Plic-1. Nat Neurosci 2001;4:908-16.
27. Wu S, Mikhailov A, Kallo-Hosein H, Hara K, Yonezawa K, Avruch J. Characterization of ubiquilin 1, an mTOR-interacting protein. Biochim Biophys Acta 2002;1542:41-56.
28. Massey LK, Mah AL, Ford DL, et al. Overexpression of ubiquilin decreases ubiquitination and degradation of presenilin proteins. J Alzheimers Dis 2004;6:79-92.
29. Ko HS, Uehara T, Nomura Y. Role of ubiquilin associated with protein-disulfide isomerase in the endoplasmic reticulum in stress-induced apoptotic cell death. J Biol Chem 2002;277:35386-92.
30. Farrer LA, Cupples LA, Haines JL, et al. Effects ofage, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA 1997;278:1349-56.
31. Pfeiffer RM, Gail MH. Sample size caldilations for population- and family-based case-control association studies on marker genotypes. Genet Epidemiol 2003;25:136-48.